cas 2306268-80-2|| where to buy 7-methyl-7-azaspiro[3.5]nonan-2-one

Nom du produit:7-methyl-7-azaspiro[3.5]nonan-2-one

IUPAC Name:7-methyl-7-azaspiro[3.5]nonan-2-one

Unité d'emballage	Stock disponible	Prix($)
CM773735-100mg	in stock	ƓŉǊ
CM773735-250mg	in stock	ƓŢǵ
CM773735-500mg	in stock	ǵǤǤ
CM773735-1g	in stock	ŉǊƓ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2306268-80-2 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:2306268-80-2; Formule moléculaire:C9H15NO; Point de fusion:-; Code SMILES:CN1CCC2(CC(=O)C2)CC1; Densité:

: Numéro de catalogue:CM773735; Poids moléculaire:153.23; Point d'ébullition:; N° Mdl:MFCD31808201; Stockage:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.